Post Profile






Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Endarterectomy

MyHeart MyHeart - Take Control of Your Health Chronic thromboembolic pulmonary hypertension (CTEPH) is an uncommon disease but an important one for several reasons – it is substantially under recognized, it may result [...]Read More The post Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Endarterectomy appeared first on MyHeart.
read more

share

Related Posts


Update on chronic thromboembolic pulmonary hypertension

Industries / Medical : Notes from Dr. RW

From Current Opinion in Pulmonary Medicine: Recent findings The pathobiology of CTEPH development remains incompletely understood; however, evidence supports both large and small vessel disorder in patients with the disease. Surgica...

Novel pulmonary hypertension drug proves safe and effective in Phase III Trial

Academics / General Science : Science Codex

ATS 2014, SAN DIEGO ? After a year of being treated with a novel drug, patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) and those with persistent or recurrent pulmonary hypertension after an operation f...

Patients with Low Pulmonary Vascular Resistance May Benefit from Complex Procedure Usually Offered Only for Patients with Pulmonary Hypertension

Health : Newswise Medical News

Patients with chronic pulmonary thromboembolic disease may benefit from pulmonary thromboendarterectomy (PTE), even if the patients don't have severe pulmonary hypertension, according to University of California, San Diego, research...

Bayer Schering Pharma Presents Positive Results Of Phase II Study With Riociguat

Health : Medical News Today

Positive data from a phase II trial with Bayer Schering Pharma's oral agent riociguat for the treatment of two different forms of pulmonary hypertension (PH); chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arter...

Grant Gives New Breath to Patients Suffering from Severe Pulmonary Hypertension

Health : Newswise Medical News

UC San Diego Health System is a world leader in chronic thromboembolic pulmonary hypertension and now with a $7.6 million grant, has helped launch the first national CTEPH registry to improve best practices and patient care.

Comments


Copyright © 2016 Regator, LLC